Dr. Peter Small is the Chief Medical Officer of Hyfe, a company pioneering the use of acoustic AI to improve human health. Dr. Small has spent his career focusing on developing and delivering innovative solutions to improve health globally. His long standing interest in tuberculosis began while Chief Medical Resident under Dr. Phil Hopewell at UCSF during the dawn of the HIV epidemic. He completed an Infectious Disease fellowship and spent about a decade on the faculty at Stanford Medical School. During these years, he published molecular epidemiological papers that helped to shape the public health response to the resurgence of tuberculosis.
In 2002 he joined the Gates Foundation where he built and ran their TB program. This included overseeing a large product development program including products such as Cepheid’s GeneXpert, GSK’s TB vaccine and the TB Alliance’s drug regimen for drug resistant TB. In 2011, he relocated to India where he established the foundation’s tuberculosis program in India. In 2015 he joined Stony Brook University as the Founding Director of the University-wide Global Health Institute focused on the use of drones and other technology to deliver health care in remote Madagascar and Nepal.
He served for two years as a Founding Fellow at the Rockefeller foundation focused on how technology can improve health in Low and Middle Income countries and as the medical lead for Bill Gates’ design build firm, GH Labs.
